| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | 233,300 | 21,431,000 | 3.89% | ||
| 2 | CELGENE CORP | 210,550 | 21,074,000 | 3.82% | ||
| 3 | MEDTRONIC INC | 276,500 | 20,738,000 | 3.76% | ||
| 4 | BIOGEN INC | 76,540 | 19,925,000 | 3.62% | ||
| 5 | ABBOTT LABS | 381,500 | 15,958,000 | 2.90% | ||
| 6 | AMGEN INC | 103,000 | 15,443,000 | 2.80% | ||
| 7 | BECTON DICKINSON & CO | 100,225 | 15,216,000 | 2.76% | ||
| 8 | ILLUMINA INC | 91,625 | 14,853,000 | 2.70% | ||
| 9 | STRYKER CORP | 125,000 | 13,411,000 | 2.43% | ||
| 10 | CARDINAL HEALTH INC | 159,630 | 13,082,000 | 2.37% | ||
| 11 | UNITEDHEALTH GROUP INC | 93,000 | 11,988,000 | 2.18% | ||
| 12 | REGENERON PHARMACEUTICALS | 32,400 | 11,678,000 | 2.12% | ||
| 13 | TEVA PHARMACEUTICAL INDS LTD | 195,290 | 10,450,000 | 1.90% | ||
| 14 | Mylan Inc | 220,000 | 10,197,000 | 1.85% | ||
| 15 | BOSTON SCIENTIFIC CORP | 500,000 | 9,405,000 | 1.71% | ||
| 16 | ZIMMER BIOMET HLDGS INC | 86,200 | 9,192,000 | 1.67% | ||
| 17 | CVS HEALTH CORP | 86,200 | 8,942,000 | 1.62% | ||
| 18 | LIGAND PHARMACEUTICALS INC | 81,830 | 8,763,000 | 1.59% | ||
| 19 | JAZZ PHARMACEUTICALS PLC SHS USD | 62,500 | 8,159,000 | 1.48% | ||
| 20 | AURIS MED HLDG AG | 2,169,625 | 7,897,000 | 1.43% | ||
| 21 | INTUITIVE SURGICAL INC | 13,000 | 7,814,000 | 1.42% | ||
| 22 | ALEXION PHARMACEUTIC | 49,400 | 6,877,000 | 1.25% | ||
| 23 | MCKESSON CORP | 43,000 | 6,762,000 | 1.23% | ||
| 24 | SUPERNUS PHARMACEUTICALS INC COM | 441,000 | 6,725,000 | 1.22% | ||
| 25 | ST JUDE | 122,000 | 6,710,000 | 1.22% | ||
| 26 | INCYTE | 91,000 | 6,595,000 | 1.20% | ||
| 27 | CIGNA CORPORATION | 48,000 | 6,588,000 | 1.20% | ||
| 28 | CENTENE CORP DEL | 105,880 | 6,519,000 | 1.18% | ||
| 29 | EDWARDS LIFESCIENCES CORP | 73,000 | 6,439,000 | 1.17% | ||
| 30 | COHERUS BIOSCIENCES INC COM | 287,000 | 6,093,000 | 1.11% | ||
| 31 | SHIRE PLC | 33,880 | 5,824,000 | 1.06% | ||
| 32 | IONIS PHARMACEUTICALS INC | 138,000 | 5,589,000 | 1.01% | ||
| 33 | HUMANA | 30,000 | 5,489,000 | 1.00% | ||
| 34 | JOHNSON & JOHNSON | 50,000 | 5,410,000 | 0.98% | ||
| 35 | MALLINCKRODT PUB LTD CO SHS | 88,000 | 5,393,000 | 0.98% | ||
| 36 | BIOMARIN | 65,000 | 5,361,000 | 0.97% | ||
| 37 | BAXTER INTL INC | 130,000 | 5,340,000 | 0.97% | ||
| 38 | VERTEX PHARMACEUT | 66,000 | 5,246,000 | 0.95% | ||
| 39 | HORIZON PHARMA PLC | 310,000 | 5,137,000 | 0.93% | ||
| 40 | BARD C R INC | 25,000 | 5,067,000 | 0.92% | ||
| 41 | AETNA INC NEW | 45,000 | 5,056,000 | 0.92% | ||
| 42 | ENDO INTL | 171,000 | 4,814,000 | 0.87% | ||
| 43 | HCA HOLDINGS INC | 60,000 | 4,683,000 | 0.85% | ||
| 44 | INSYS THERAPEUTICS INC NEW COM NEW | 281,000 | 4,493,000 | 0.82% | ||
| 45 | PERRIGO CO PLC | 32,600 | 4,171,000 | 0.76% | ||
| 46 | ANTHEM INC | 30,000 | 4,170,000 | 0.76% | ||
| 47 | EXPRESS SCRIPTS HLDG CO | 58,600 | 4,025,000 | 0.73% | ||
| 48 | Intersect ENT Inc | 209,246 | 3,976,000 | 0.72% | ||
| 49 | BRISTOL MYERS SQUIBB CO | 60,000 | 3,833,000 | 0.70% | ||
| 50 | EAGLE BANCORP INC MD | 93,400 | 3,783,000 | 0.69% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017418, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
